Clive Morris - Dec 30, 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
President of Inivata
Signature
/s/ Clive Morris
Stock symbol
NEO
Transactions as of
Dec 30, 2021
Transactions value $
$0
Form type
4
Date filed
12/30/2021, 05:05 PM
Previous filing
Jul 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +30.6K +285.51% $0.00 41.3K Dec 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 53.9K Dec 30, 2021 Common Stock 53.9K $43.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 30, 2021, Mr. Morris was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
F2 On June 18, 2021, Mr. Morris was granted 53,857 stock options. The options vest ratably over the first four anniversary dates of the grant date.